INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,568,223 | -73.5% | 28,024 | -75.5% | 0.01% | -73.5% |
| Q2 2022 | $5,921,499 | -47.3% | 114,403 | -26.1% | 0.05% | -31.0% |
| Q1 2022 | $11,245,392 | +5.5% | 154,746 | +71.7% | 0.07% | +14.5% |
| Q4 2021 | $10,656,025 | -28.9% | 90,122 | -19.3% | 0.06% | -43.6% |
| Q3 2021 | $14,990,055 | -30.8% | 111,741 | -16.4% | 0.11% | -19.1% |
| Q2 2021 | $21,647,367 | +122.1% | 133,700 | +10.1% | 0.14% | +58.1% |
| Q1 2021 | $9,747,211 | +646.6% | 121,453 | +406.1% | 0.09% | +681.8% |
| Q4 2020 | $1,305,600 | +406.0% | 24,000 | +84.6% | 0.01% | +266.7% |
| Q3 2020 | $258,000 | -64.2% | 13,000 | -73.6% | 0.00% | -50.0% |
| Q4 2019 | $721,000 | – | 49,175 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
| ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
| Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
| Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
| 361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
| Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
| StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
| Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
| PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |